For more than a decade, PTC Therapeutics has been going back and forth with the FDA to find a path forward for a Duchenne muscular dystrophy drug with a spotty track record in clinical testing. That ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...

The FDA stated that ataluren data lacked the substantial evidence of effectiveness needed for approval, leading PTC Therapeutics to withdraw its NDA. Following discussions with the Food and Drug ...

PTC Inc. (NASDAQ:PTC) Q1 2026 Earnings Call Transcript February 4, 2026 PTC Inc. beats earnings expectations. Reported EPS is $119797.12, expectations were $1.59. Operator: Good evening, ladies and ...

DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

What are the best Hytale servers? Just like Minecraft, Hytale is a fantastic game to explore alone, but it's so much better with others. After years spent making friends in Minecraft servers, we've ...

PTC releases Codebeamer 3.2, Codebeamer AI 1.0, and Pure Variants 7.2 Codebeamer 3.2 and Pure Variants 7.2 strengthen product data foundation for regulated, software-driven product development, ...

Ubisoft had to shut down Rainbow Six Siege's servers and roll back transactions, a situation that came from a widespread breach that left various players with billions of in-game credits, ultra-rare ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Seaport-based software ...

LAS VEGAS, Dec. 18, 2025 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that it will demonstrate how Automobili Lamborghini S.p.A can leverage the Intelligent Product Lifecycle to improve the ...

New York City-based Armistice Capital sold 1,458,192 shares of PTC Therapeutics for an estimated $30.2 million in the third quarter. At quarter-end, Armistice reporting holding a total of nearly 3.3 ...